ArticlePLoS medicine2020

Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study.

Anthony Fenton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.